IONS logo

Ionis Pharmaceuticals, Inc. (IONS) EBITDA

Annual EBITDA:

-$353.72M-$117.85M(-49.96%)
December 31, 2024

Summary

  • As of today, IONS annual EBITDA is -$353.72 million, with the most recent change of -$117.85 million (-49.96%) on December 31, 2024.
  • During the last 3 years, IONS annual EBITDA has fallen by -$348.53 million (-6718.06%).
  • IONS annual EBITDA is now -196.33% below its all-time high of $367.20 million, reached on December 31, 2019.

Performance

IONS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

Quarterly EBITDA:

-$155.68M-$300.95M(-207.17%)
September 1, 2025

Summary

  • As of today, IONS quarterly EBITDA is -$155.68 million, with the most recent change of -$300.95 million (-207.17%) on September 1, 2025.
  • Over the past year, IONS quarterly EBITDA has dropped by -$12.52 million (-8.74%).
  • IONS quarterly EBITDA is now -158.81% below its all-time high of $264.73 million, reached on December 31, 2019.

Performance

IONS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

TTM EBITDA:

-$256.61M-$12.52M(-5.13%)
September 1, 2025

Summary

  • As of today, IONS TTM EBITDA is -$256.61 million, with the most recent change of -$12.52 million (-5.13%) on September 1, 2025.
  • Over the past year, IONS TTM EBITDA has increased by +$91.32 million (+26.25%).
  • IONS TTM EBITDA is now -167.38% below its all-time high of $380.84 million, reached on December 31, 2019.

Performance

IONS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

IONS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-50.0%-8.7%+26.3%
3Y3 Years-6718.1%-188.0%-759.9%
5Y5 Years-196.3%-385.2%-300.6%

IONS EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-6718.1%at low-207.2%+22.5%-759.9%+51.7%
5Y5-Year-196.3%at low-168.9%+22.5%-300.6%+51.7%
All-TimeAll-Time-196.3%at low-158.8%+22.5%-167.4%+51.7%

IONS EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$155.68M(-207.2%)
-$256.61M(-5.1%)
Jun 2025
-
$145.27M(+202.7%)
-$244.09M(+45.7%)
Mar 2025
-
-$141.46M(-35.1%)
-$449.87M(+0.5%)
Dec 2024
-$353.72M(-50.0%)
-$104.73M(+26.8%)
-$452.27M(-30.0%)
Sep 2024
-
-$143.16M(-136.6%)
-$347.93M(-1.6%)
Jun 2024
-
-$60.51M(+57.9%)
-$342.44M(+6.5%)
Mar 2024
-
-$143.86M(>-9900.0%)
-$366.43M(-10.7%)
Dec 2023
-$235.87M(-3.6%)
-$388.00K(+99.7%)
-$331.11M(+37.7%)
Sep 2023
-
-$137.67M(-62.9%)
-$531.69M(-18.7%)
Jun 2023
-
-$84.51M(+22.1%)
-$448.08M(-0.9%)
Mar 2023
-
-$108.54M(+46.0%)
-$444.00M(-14.4%)
Dec 2022
-$227.76M(-4290.1%)
-$200.97M(-271.8%)
-$388.07M(-1097.9%)
Sep 2022
-
-$54.06M(+32.8%)
$38.89M(+229.4%)
Jun 2022
-
-$80.43M(-52.9%)
$11.80M(-51.4%)
Mar 2022
-
-$52.61M(-123.3%)
$24.28M(+337.3%)
Dec 2021
-$5.19M(+95.3%)
$225.98M(+378.5%)
-$10.23M(+96.0%)
Sep 2021
-
-$81.14M(-19.4%)
-$254.65M(-23.9%)
Jun 2021
-
-$67.95M(+22.0%)
-$205.59M(-10.9%)
Mar 2021
-
-$87.12M(-372.6%)
-$185.36M(-19.4%)
Dec 2020
-$111.19M(-130.3%)
-$18.43M(+42.5%)
-$155.26M(-221.4%)
Sep 2020
-
-$32.09M(+32.8%)
$127.91M(-23.0%)
Jun 2020
-
-$47.72M(+16.3%)
$166.20M(-16.4%)
Mar 2020
-
-$57.02M(-121.5%)
$198.75M(-47.8%)
Dec 2019
$367.20M(+2049.1%)
$264.73M(+4167.1%)
$380.84M(+192.0%)
Sep 2019
-
$6.20M(+140.9%)
$130.42M(+19.8%)
Jun 2019
-
-$15.17M(-112.1%)
$108.89M(+41.9%)
Mar 2019
-
$125.08M(+774.4%)
$76.73M(+257.1%)
Dec 2018
-$18.84M(-151.8%)
$14.30M(+193.4%)
-$48.84M(+28.5%)
Sep 2018
-
-$15.32M(+67.6%)
-$68.35M(-74.5%)
Jun 2018
-
-$47.33M(-9462.4%)
-$39.16M(-329.8%)
Mar 2018
-
-$495.00K(+90.5%)
$17.04M(-56.7%)
Dec 2017
$36.34M(+477.0%)
-$5.21M(-137.5%)
$39.40M(-55.2%)
Sep 2017
-
$13.87M(+56.4%)
$88.03M(-5.6%)
Jun 2017
-
$8.87M(-59.4%)
$93.23M(+146.6%)
Mar 2017
-
$21.86M(-49.7%)
$37.81M(+204.8%)
Dec 2016
-$9.64M(+76.5%)
$43.42M(+127.6%)
-$36.08M(+74.2%)
Sep 2016
-
$19.08M(+141.0%)
-$139.82M(+31.6%)
Jun 2016
-
-$46.55M(+10.5%)
-$204.42M(-84.9%)
Mar 2016
-
-$52.03M(+13.7%)
-$110.58M(-68.8%)
Dec 2015
-$40.94M(-79.7%)
-$60.31M(-32.5%)
-$65.52M(-1006.9%)
Sep 2015
-
-$45.52M(-196.3%)
$7.22M(-78.5%)
Jun 2015
-
$47.28M(+777.6%)
$33.67M(+287.8%)
Mar 2015
-
-$6.98M(-156.1%)
-$17.93M(+53.2%)
Dec 2014
-$22.78M(+39.1%)
$12.44M(+165.2%)
-$38.33M(+45.3%)
Sep 2014
-
-$19.07M(-341.5%)
-$70.05M(+7.7%)
Jun 2014
-
-$4.32M(+84.2%)
-$75.89M(+3.2%)
Mar 2014
-
-$27.37M(-42.0%)
-$78.42M(-62.2%)
Dec 2013
-$37.42M(+12.3%)
-$19.28M(+22.6%)
-$48.34M(-0.3%)
Sep 2013
-
-$24.92M(-263.6%)
-$48.20M(+2.6%)
Jun 2013
-
-$6.85M(-353.3%)
-$49.49M(-32.3%)
Mar 2013
-
$2.71M(+114.1%)
-$37.39M(+36.1%)
Dec 2012
-$42.68M(+24.2%)
-$19.14M(+27.0%)
-$58.55M(-11.0%)
Sep 2012
-
-$26.20M(-599.7%)
-$52.77M(-19.1%)
Jun 2012
-
$5.24M(+128.4%)
-$44.32M(+25.2%)
Mar 2012
-
-$18.45M(-38.2%)
-$59.27M(-15.1%)
Dec 2011
-$56.27M
-$13.35M(+24.8%)
-$51.52M(-35.0%)
Sep 2011
-
-$17.76M(-82.9%)
-$38.16M(-87.0%)
DateAnnualQuarterlyTTM
Jun 2011
-
-$9.71M(+9.3%)
-$20.41M(-90.7%)
Mar 2011
-
-$10.70M(+37.9%)
-$10.70M(+69.6%)
Dec 2010
-$38.75M(-295.8%)
-
-
Dec 2009
-$9.79M(-338.2%)
-
-
Dec 2008
$4.11M(+115.7%)
-
-
Dec 2007
-$26.15M(+55.3%)
-
-
Dec 2006
-$58.54M(-46.9%)
-
-
Dec 2005
-$39.84M(+45.6%)
-
-
Dec 2004
-$73.26M(-12.8%)
-
-
Dec 2003
-$64.92M(-62.2%)
-
-
Dec 2002
-$40.02M(-2.3%)
-
-
Dec 2001
-$39.13M(-66.9%)
-
-
Mar 2001
-
-$17.23M(-72.1%)
-$35.22M(-21.5%)
Dec 2000
-$23.45M(+38.1%)
-$10.01M(-4960.2%)
-$28.99M(+7.9%)
Sep 2000
-
$206.00K(+102.5%)
-$31.48M(+20.9%)
Jun 2000
-
-$8.18M(+25.7%)
-$39.78M(+8.8%)
Mar 2000
-
-$11.01M(+11.9%)
-$43.61M(-1.2%)
Dec 1999
-$37.90M(-34.4%)
-$12.50M(-54.3%)
-$43.10M(-6.9%)
Sep 1999
-
-$8.10M(+32.5%)
-$40.30M(-29.6%)
Jun 1999
-
-$12.00M(-14.3%)
-$31.10M(+3.1%)
Mar 1999
-
-$10.50M(-8.2%)
-$32.10M(+1.5%)
Dec 1998
-$28.20M(-0.4%)
-$9.70M(-981.8%)
-$32.60M(+1.8%)
Sep 1998
-
$1.10M(+108.5%)
-$33.20M(+10.0%)
Jun 1998
-
-$13.00M(-18.2%)
-$36.90M(-9.8%)
Mar 1998
-
-$11.00M(-6.8%)
-$33.60M(-6.7%)
Dec 1997
-$28.10M(-6.0%)
-$10.30M(-296.2%)
-$31.50M(-2.6%)
Sep 1997
-
-$2.60M(+73.2%)
-$30.70M(+11.8%)
Jun 1997
-
-$9.70M(-9.0%)
-$34.80M(-4.8%)
Mar 1997
-
-$8.90M(+6.3%)
-$33.20M(-14.1%)
Dec 1996
-$26.50M(-16.2%)
-$9.50M(-41.8%)
-$29.10M(-12.8%)
Sep 1996
-
-$6.70M(+17.3%)
-$25.80M(+2.6%)
Jun 1996
-
-$8.10M(-68.8%)
-$26.50M(-8.6%)
Mar 1996
-
-$4.80M(+22.6%)
-$24.40M(+5.1%)
Dec 1995
-$22.80M(-22.6%)
-$6.20M(+16.2%)
-$25.70M(+16.3%)
Sep 1995
-
-$7.40M(-23.3%)
-$30.70M(-8.5%)
Jun 1995
-
-$6.00M(+1.6%)
-$28.30M(-4.4%)
Mar 1995
-
-$6.10M(+45.5%)
-$27.10M(-6.3%)
Dec 1994
-$18.60M(-23.2%)
-$11.20M(-124.0%)
-$25.50M(-36.4%)
Sep 1994
-
-$5.00M(-4.2%)
-$18.70M(-3.3%)
Jun 1994
-
-$4.80M(-6.7%)
-$18.10M(-1.1%)
Mar 1994
-
-$4.50M(-2.3%)
-$17.90M(+3.2%)
Dec 1993
-$15.10M(+23.0%)
-$4.40M(0.0%)
-$18.50M(+11.5%)
Sep 1993
-
-$4.40M(+4.3%)
-$20.90M(-0.5%)
Jun 1993
-
-$4.60M(+9.8%)
-$20.80M(-4.5%)
Mar 1993
-
-$5.10M(+25.0%)
-$19.90M(-2.1%)
Dec 1992
-$19.60M(-104.2%)
-$6.80M(-58.1%)
-$19.50M(-11.4%)
Sep 1992
-
-$4.30M(-16.2%)
-$17.50M(-15.1%)
Jun 1992
-
-$3.70M(+21.3%)
-$15.20M(-11.8%)
Mar 1992
-
-$4.70M(+2.1%)
-$13.60M(-34.7%)
Dec 1991
-$9.60M(-134.1%)
-$4.80M(-140.0%)
-$10.10M(+10.6%)
Sep 1991
-
-$2.00M(+4.8%)
-$11.30M(-28.4%)
Jun 1991
-
-$2.10M(-75.0%)
-$8.80M(-41.9%)
Mar 1991
-
-$1.20M(+80.0%)
-$6.20M(-37.8%)
Dec 1990
-$4.10M
-$6.00M(-1300.0%)
-$4.50M(-400.0%)
Sep 1990
-
$500.00K(0.0%)
$1.50M(+50.0%)
Jun 1990
-
$500.00K(0.0%)
$1.00M(+100.0%)
Mar 1990
-
$500.00K
$500.00K

FAQ

  • What is Ionis Pharmaceuticals, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. annual EBITDA year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. TTM EBITDA year-on-year change?

What is Ionis Pharmaceuticals, Inc. annual EBITDA?

The current annual EBITDA of IONS is -$353.72M

What is the all-time high annual EBITDA for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high annual EBITDA is $367.20M

What is Ionis Pharmaceuticals, Inc. annual EBITDA year-on-year change?

Over the past year, IONS annual EBITDA has changed by -$117.85M (-49.96%)

What is Ionis Pharmaceuticals, Inc. quarterly EBITDA?

The current quarterly EBITDA of IONS is -$155.68M

What is the all-time high quarterly EBITDA for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high quarterly EBITDA is $264.73M

What is Ionis Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?

Over the past year, IONS quarterly EBITDA has changed by -$12.52M (-8.74%)

What is Ionis Pharmaceuticals, Inc. TTM EBITDA?

The current TTM EBITDA of IONS is -$256.61M

What is the all-time high TTM EBITDA for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high TTM EBITDA is $380.84M

What is Ionis Pharmaceuticals, Inc. TTM EBITDA year-on-year change?

Over the past year, IONS TTM EBITDA has changed by +$91.32M (+26.25%)
On this page